Aspirin is one of the oldest and most effective over-the-counter anti-inflammatory drugs available, but whether it is “good” for inflammation depends heavily on the type of inflammation, the dose, and the person taking it. It works by blocking the enzymes that drive swelling and pain, and doctors still rely on it for specific inflammatory conditions where few alternatives perform as well. The catch is that the same properties that make aspirin a potent anti-inflammatory also create real risks, particularly to the stomach lining and the body’s ability to form blood clots.
How Aspirin Fights Inflammation
Aspirin’s core job is to shut down cyclooxygenase, or COX, the enzyme responsible for producing prostaglandins that trigger pain, swelling, and fever. Unlike ibuprofen or naproxen, which block COX temporarily, aspirin permanently disables it by attaching an acetyl group to the enzyme. The enzyme stays blocked for the life of the cell that contains it.1Journal of the American Chemical Society. Mechanistic Insights into a Classic Wonder Drug─Aspirin – Section: Results That irreversible action is what makes aspirin uniquely useful for preventing blood clots at low doses but also why its side effects can linger longer than those of other pain relievers.
Aspirin also appears to have anti-inflammatory effects beyond COX inhibition. Research has shown that aspirin and its breakdown product, salicylate, block the activation of NF-kappa B, a protein complex that acts as a master switch for inflammation-related genes. By keeping that switch in the “off” position, aspirin reduces the production of inflammatory signaling molecules at the genetic level.2PubMed. Inhibition of NF-kappa B by sodium salicylate and aspirin This dual mechanism, blocking both the enzyme that makes inflammatory chemicals and the gene switch that orders more of them, helps explain why aspirin remains relevant even with newer drugs on the market.
Inflammatory Conditions Where Aspirin Is Still a Go-To
For general aches, headaches, and minor inflammation, most people now reach for ibuprofen or naproxen. But aspirin occupies a specific clinical niche in a few inflammatory conditions where it performs well and has strong evidence behind it.
Pericarditis, the painful inflammation of the sac surrounding the heart, is one of the clearest examples. Aspirin and other anti-inflammatory drugs are the standard first-line treatment, providing symptom relief and reducing the chance of recurrence.3PubMed Central. Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis Rheumatic pericarditis, a complication of rheumatic fever, also responds to high-dose aspirin, sometimes resolving chest pain effectively when paired with antibiotics.4Journal of Taibah University Medical Sciences. A case report of isolated rheumatic tricuspid regurgitation and pericarditis
Kawasaki disease, a condition that causes dangerous blood vessel inflammation in young children, is another case where aspirin remains part of the standard treatment protocol alongside intravenous immunoglobulin.5PubMed Central. Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease That said, the role of high-dose aspirin in Kawasaki disease is increasingly debated. Some research suggests that the high-dose phase may not actually prevent coronary artery damage and could even raise the risk of coronary complications and recurrent fever when continued for several weeks.6European Journal of Inflammation. Impact of aspirin dosage on prognosis and coronary artery complications in pediatric Kawasaki disease patients Another study concluded that dropping the high-dose phase entirely and relying on immunoglobulin alone did not increase the risk of coronary artery problems.7PubMed Central. Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm – Section: CONCLUSIONS So even in conditions where aspirin has been a fixture for decades, clinicians are reexamining exactly how much is necessary.
How Aspirin Compares to Other Anti-Inflammatory Painkillers
If you are deciding between aspirin and another over-the-counter option for pain or inflammation, the honest answer is that aspirin is often not the first choice anymore. In a head-to-head trial comparing naproxen sodium and aspirin for pain relief, naproxen provided faster and stronger relief, maintained that advantage over time, and produced fewer side effects.8PubMed. Comparative analgesic effects of naproxen sodium, aspirin, and placebo Ibuprofen has similarly displaced aspirin for everyday aches in most clinical guidelines, largely because it is gentler on the stomach at equivalent anti-inflammatory doses.
Aspirin’s real remaining advantage is in situations where its irreversible COX blockade and antiplatelet effect are desirable, like cardiovascular protection after a heart attack or stroke, or in the inflammatory conditions described above. For a sore back or a swollen ankle, though, you are generally better served by a newer anti-inflammatory.
The Stomach Problem
Aspirin’s most notorious side effect is damage to the gastrointestinal tract. This is not a rare complication that happens only at high doses; even the low doses used for heart protection can cause problems over time. The damage happens through two pathways working together. First, when aspirin is absorbed, its breakdown product salicylate is directly toxic to the cells lining the stomach, disrupting the protective mucus barrier and making the tissue more vulnerable to acid. Second, by blocking COX, aspirin reduces prostaglandin production, and prostaglandins are precisely what the stomach relies on to produce protective mucus, maintain blood flow to the lining, and keep acid in check.9PubMed. Aspirin-induced gastric mucosal injury: lessons learned from animal models The result is a one-two punch: the lining is weakened and the body’s ability to repair it is simultaneously impaired.
The damage is not limited to the stomach. Aspirin can injure the lining of the small intestine and colon as well, and some of that injury comes from aspirin’s effects on gut bacteria, which can trigger local inflammation through immune signaling.10Frontiers in Pharmacology. Inhibition of Aspirin-Induced Gastrointestinal Injury: Systematic Review and Network Meta-Analysis – Section: Discussion This matters because many people on long-term low-dose aspirin assume the risk is confined to stomach ulcers, when the entire digestive tract is at play.
The good news is that proton pump inhibitors, the acid-suppressing drugs like omeprazole, dramatically reduce this risk. A meta-analysis found that adding a proton pump inhibitor cut the odds of aspirin-related upper GI ulcers by about 84% and the odds of GI bleeding by roughly 73%.11PubMed Central. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries – Section: RESULTS If you are on long-term aspirin and your doctor has not discussed stomach protection, it is worth bringing up.
Bleeding Risks Beyond the Gut
Because aspirin permanently disables COX in platelets, those platelets can no longer help form clots for the rest of their roughly ten-day lifespan. That is the basis of aspirin’s blood-thinning benefit after heart attacks, but it also means bleeding anywhere in the body becomes harder to stop.
A systematic review for the U.S. Preventive Services Task Force found that even very low-dose aspirin, 100 mg daily or less, increased the risk of major gastrointestinal bleeding by about 58% and raised the risk of hemorrhagic stroke by about 27% in people taking it for primary prevention.12PubMed. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force In absolute terms, those risks translate to roughly one to two extra major GI bleeding events per thousand people per year of aspirin use, numbers that sound small individually but add up across millions of users.
Observational studies largely confirm those numbers. One systematic review estimated the relative risk of GI bleeding with low-dose aspirin at about 1.4 overall, but the risk of upper GI bleeding specifically was higher, closer to a 2.3-fold increase. The risk worsened when aspirin was combined with other anti-inflammatory drugs, certain antidepressants, or the blood thinner clopidogrel.13PubMed Central. Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
Intracranial bleeding is the most serious concern. In the ASPREE trial, which studied healthy adults over 70, the aspirin group experienced significantly more intracranial bleeding than the placebo group. The excess of 29 intracranial bleeding events in the aspirin group actually outweighed the 20 fewer ischemic strokes aspirin prevented.14PubMed Central. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People – Section: Results That math, where aspirin caused more harm from bleeding than it prevented from strokes, was a major reason the consensus on aspirin for primary prevention shifted.
Why Doctors Stopped Recommending Aspirin for Healthy Hearts
For decades, a daily baby aspirin was treated almost like a vitamin for middle-aged and older adults worried about heart disease. That era is over. The same ASPREE trial found that in healthy older adults, aspirin did not significantly reduce heart attacks, strokes, or cardiovascular deaths compared to placebo, but it did significantly increase major hemorrhage.15PubMed. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly The bleeding risk simply outweighed the marginal cardiovascular benefit in people who had never had a heart attack or stroke.
Current guidelines reflect this shift. Aspirin is no longer recommended for routine primary prevention of cardiovascular disease in older adults.16PubMed Central. Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults For people who have already had a stroke or heart attack, the calculation is entirely different. In that group, long-term aspirin reduces the risk of another stroke, heart attack, or vascular death, and the benefit clearly outweighs the bleeding risk.17PubMed. Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review The key distinction is primary prevention (no prior event) versus secondary prevention (already had one). If you are currently taking daily aspirin and have never had a cardiovascular event, it is worth discussing with your doctor whether continuing makes sense.
Low-Dose Aspirin in Pregnancy
One of the more surprising uses of aspirin’s anti-inflammatory and antiplatelet properties is in pregnancy. Low-dose aspirin is commonly prescribed to women at high risk of preeclampsia, a dangerous condition involving high blood pressure and organ damage. A meta-analysis found that low-dose aspirin reduced the odds of preeclampsia by about 29%, cut the risk of severe preeclampsia by more than 60%, and also lowered rates of preterm birth and fetal growth restriction, all without major safety concerns for mothers or babies.18PubMed Central. Low-Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta-Analysis
The evidence is not perfectly uniform, though. An earlier large trial found that low-dose aspirin did not significantly reduce preeclampsia in high-risk women, and outcomes like perinatal death and preterm birth were similar between aspirin and placebo groups.19PubMed. Low-dose aspirin to prevent preeclampsia in women at high risk The difference likely comes down to timing, dosing, and how “high risk” was defined. Current practice guidelines generally favor starting aspirin early in pregnancy, around the end of the first trimester, in women who have specific risk factors. It is one of the few preventive tools available for a condition that can be life-threatening, and the evidence across multiple studies, when pooled, supports its use.
Aspirin and Colorectal Cancer Prevention
One of the more intriguing areas of aspirin research has nothing to do with pain or inflammation in the usual sense. A large body of epidemiological, laboratory, and clinical evidence suggests that regular aspirin use lowers the risk of colorectal cancer. The COX-inhibiting mechanism likely plays a role, since COX-2 is overexpressed in many colorectal tumors and the prostaglandins it produces promote tumor growth and suppress the immune system’s ability to destroy cancer cells.20PubMed Central. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways
But aspirin also appears to affect cancer through pathways unrelated to COX, including effects on cell signaling and DNA repair. The precise mechanism remains unsettled, which is part of why aspirin is not yet universally recommended for cancer prevention. The U.S. Preventive Services Task Force previously included colorectal cancer prevention as one rationale for low-dose aspirin in certain adults, but the bleeding trade-offs and the difficulty of identifying who benefits most have kept this out of blanket guidelines. If you have a family history of colorectal cancer, it is a conversation worth having with a gastroenterologist, but self-prescribing aspirin for cancer prevention is not recommended.
When Aspirin Makes Inflammation Worse
In a small but significant subset of people, aspirin does not reduce inflammation; it triggers a severe inflammatory reaction. Aspirin-exacerbated respiratory disease, or AERD, is a condition characterized by adult-onset asthma, chronic sinus inflammation with nasal polyps, and intense respiratory reactions to aspirin and similar drugs. Taking even a standard dose can cause sudden bronchospasm, nasal congestion, and in some cases life-threatening breathing difficulty.21Allergology International. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD
The underlying problem appears to involve an imbalance in the same prostaglandin system that aspirin modulates. People with AERD already have reduced COX-2 activity, so when aspirin further suppresses it, protective prostaglandin E2 drops to dangerously low levels while inflammatory leukotrienes spike. The condition is thought to affect roughly 7-10% of adults with asthma, though many go undiagnosed because they have never taken aspirin. If you have asthma and nasal polyps, this is something to be aware of before taking aspirin or any similar anti-inflammatory drug.
Aspirin Resistance
Not everyone responds to aspirin the way textbooks predict. Some people continue to form blood clots or experience inflammation despite taking aspirin as directed. This phenomenon, called aspirin resistance, has been documented in roughly 5% to 65% of patients with coronary heart disease, depending on how resistance is defined and measured.22PubMed Central. Aspirin resistance in coronary heart disease: Current understandings and strategies That wide range reflects a real problem: there is no universal lab test to confirm whether aspirin is “working” in a given individual.
The causes are varied. Simple non-compliance, taking the pill inconsistently, accounts for some cases. Drug interactions play a role; taking ibuprofen around the same time as aspirin can block aspirin from reaching its target on the platelet. Genetic variation in platelet receptors matters too, and some people’s bodies simply ramp up alternative pathways for producing clot-promoting chemicals when the main one is blocked. For anyone taking aspirin long-term for a serious condition, the possibility that it may not be fully effective is worth keeping in mind, especially if a cardiovascular event occurs despite regular use.
Why You Should Not Stop Aspirin Abruptly
If you have been taking aspirin regularly and decide to stop, timing matters. Evidence suggests that abruptly stopping aspirin can create a rebound effect, a temporary surge in clotting activity that actually raises the risk of a blood vessel blockage. Clinical and experimental data indicate this rebound window falls within about four weeks of stopping.23JAMA Neurology. Effect of Discontinuing Aspirin Therapy on the Risk of Brain Ischemic Stroke Acute clotting complications tend to appear after a delay of about 8 to 25 days, roughly the time it takes for the body to replace its entire pool of platelets with new ones that aspirin has not affected.24PubMed. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence
This is particularly relevant before surgery or dental procedures, situations where aspirin is sometimes stopped to reduce surgical bleeding. The decision to pause aspirin should always be made with a doctor who can weigh the bleeding risk of the procedure against the clotting risk of stopping the drug. For anyone currently on aspirin for secondary prevention after a heart attack or stroke, stopping without medical guidance can be genuinely dangerous.
Children, Aspirin, and Reye Syndrome
One population where aspirin should almost never be used for general inflammation is children and teenagers with viral illnesses. The concern is Reye syndrome, a rare but potentially fatal condition that causes swelling in the liver and brain. Since the 1980s, public health warnings have advised against giving aspirin to children with febrile illnesses, and the incidence of Reye syndrome dropped dramatically once that guidance took hold.
The actual evidence linking aspirin to Reye syndrome is more complicated than the public health message suggests. A review of the data noted that a definitive cause-and-effect relationship between aspirin and Reye syndrome has not been established beyond question, and that other toxins and drugs may also contribute.25PubMed. Aspirin and Reye syndrome: a review of the evidence Still, the association was strong enough and the consequences severe enough that the precautionary approach stuck. Children should use ibuprofen or acetaminophen for fever and pain. The notable exception is Kawasaki disease, where aspirin is used under close medical supervision because no good alternative exists for that specific inflammatory condition.